Design and Verification of Individualized Smart Assistive Devices for Stroke Rehabilitation
NCT ID: NCT03502122
Last Updated: 2018-07-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2012-04-24
2014-05-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wireless Brain-computer-interface-controlled Neurorehabilitation System for Patients With Stroke
NCT01880268
EMG Controlled Device in Acute Rehabilitation After Acute Stroke
NCT04599036
Effectiveness of Robot-assisted Rehabilitation in Persons With Stroke
NCT04002076
Mixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation
NCT05903235
Effectiveness of Interactive Augmented Reality and Electrical Neuromodulation System in Persons With Stroke
NCT04003571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VR rehabilitation
Virtual Reality based rehabilitation therapy for motor function, 1 hour a time at an intensity of three times per week over 8 weeks (total, 24 sessions).
VR rehabilitation for motor function
rehabilitation for motor function
control- conventional rehabilitation
conventional rehabilitation therapy for motor function, 1 hour a time at an intensity of three times per week over 8 weeks (total, 24 sessions).
VR rehabilitation for motor function
rehabilitation for motor function
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VR rehabilitation for motor function
rehabilitation for motor function
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis confirmed by a physician on the basis of the findings of neurological examinations and brain imaging (magnetic resonance imaging or computed tomography scan);
* aged between 20 and 85 years;
* Brunnstrom's stage II to V over the proximal and distal part of the upper extremity on the affected side;
* no cognitive dysfunction, measured by the Mini-Mental State Exam (≧24; suggested by 36 with respect to age and educational level)
* willing/able to participate and having signed an informed consent form.
Exclusion Criteria
* irreversible contracture over any of the joints of the affected upper extremity
* history of surgery, fracture, arthritis, pain, or any other complications that might influence the recovery of upper extremity function like aphasia, apraxia and neglect;
* having spasticity, as measured using the Modified Ashworth scale (score \> 2);
* poststroke seizure;
* heart attack within 3 months poststroke; cortical lesions in any of the five core motor areas of interest, including the bilateral M1, the bilateral PM, and the SMA.
20 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Central University, Taiwan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chun-Chuan Chen
Associate professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201012009IA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.